Showing 1 - 20 results of 24 for search 'Serena Pillozzi', query time: 0.07s
Refine Results
-
1
Ion Channels in Hematopoietic and Mesenchymal Stem Cells by Serena Pillozzi, Andrea Becchetti
Published 2012-01-01
Article -
2
-
3
Unconventional strategy could be the future: From target to KRAS broad range treatment by Sara Fancelli, Giulia Petroni, Serena Pillozzi, Lorenzo Antonuzzo
Published 2024-05-01
Article -
4
-
5
Immune checkpoint blockade with anti-programmed cell death 1 (PD-1) monoclonal antibody (mAb) cemiplimab: ongoing and future perspectives in rare genital cancers treatment by Lorenzo Antonuzzo, Sara Fancelli, Maria Cristina Petrella, Elisabetta Gambale, Enrico Caliman, Laura Doni, Serena Pillozzi
Published 2022-01-01
Article -
6
-
7
Mutations matter: An observational study of the prognostic and predictive value of KRAS mutations in metastatic colorectal cancer by Daniele Lavacchi, Sara Fancelli, Sara Fancelli, Giandomenico Roviello, Francesca Castiglione, Enrico Caliman, Enrico Caliman, Gemma Rossi, Jacopo Venturini, Elisa Pellegrini, Marco Brugia, Agnese Vannini, Caterina Bartoli, Fabio Cianchi, Serena Pillozzi, Serena Pillozzi, Lorenzo Antonuzzo, Lorenzo Antonuzzo, Lorenzo Antonuzzo
Published 2022-11-01
Article -
8
-
9
-
10
Transgenic mice overexpressing the LH receptor in the female reproductive system spontaneously develop endometrial tumour masses by Tiziano Lottini, Jessica Iorio, Elena Lastraioli, Laura Carraresi, Claudia Duranti, Cesare Sala, Miriam Armenio, Ivo Noci, Serena Pillozzi, Annarosa Arcangeli
Published 2021-04-01
Article -
11
Targeting KCa3.1 channels to overcome erlotinib resistance in non-small cell lung cancer cells by Luca Matteo Todesca, Matthias Gerke, Emma Etmar Bulk, Magdalena Bachmann, Alisa Rudersdorf, Lorenzo Antonuzzo, Serena Pillozzi, Martina Düfer, Ildiko Szabo, Albrecht Schwab
Published 2024-01-01
Article -
12
A Machine Learning Decision Support System (DSS) for Neuroendocrine Tumor Patients Treated with Somatostatin Analog (SSA) Therapy by Jasminka Hasic Telalovic, Serena Pillozzi, Rachele Fabbri, Alice Laffi, Daniele Lavacchi, Virginia Rossi, Lorenzo Dreoni, Francesca Spada, Nicola Fazio, Amedeo Amedei, Ernesto Iadanza, Lorenzo Antonuzzo
Published 2021-04-01
Article -
13
Circulating miRNome profiling data in Behçet's syndrome by Giacomo Bagni, Giacomo Emmi, Elena Lastraioli, Francesca Di Patti, Elena Silvestri, Angela Guerriero, Serena Pillozzi, Elena Niccolai, Amedeo Amedei, Lorenzo Emmi, Domenico Prisco, Annarosa Arcangeli
Published 2021-10-01
Article -
14
Impact of natremia on metastatic non small cell lung cancer patients receiving immune checkpoint inhibitors by Martina Catalano, Sara Fancelli, Enrico Caliman, Francesca Mazzoni, Marta Gatta Michelet, Silvia Mancini, Clara Manneschi, Sonia Shabani, Brunella Napolitano, Serena Pillozzi, Lorenzo Antonuzzo, Giandomenico Roviello
Published 2024-11-01
Article -
15
Eosinophil Count as Predictive Biomarker of Immune-Related Adverse Events (irAEs) in Immune Checkpoint Inhibitors (ICIs) Therapies in Oncological Patients by Elisa Giommoni, Roberta Giorgione, Agnese Paderi, Elisa Pellegrini, Elisabetta Gambale, Andrea Marini, Andrea Antonuzzo, Riccardo Marconcini, Giandomenico Roviello, Marco Matucci-Cerinic, David Capaccioli, Serena Pillozzi, Lorenzo Antonuzzo
Published 2021-08-01
Article -
16
Association of Systemic Steroid Treatment and Outcome in Patients Treated with Immune Checkpoint Inhibitors: A Real-World Analysis by Agnese Paderi, Elisabetta Gambale, Cristina Botteri, Roberta Giorgione, Daniele Lavacchi, Marco Brugia, Francesca Mazzoni, Elisa Giommoni, Susanna Bormioli, Amedeo Amedei, Serena Pillozzi, Marco Matucci Cerinic, Lorenzo Antonuzzo
Published 2021-09-01
Article -
17
KRAS-related miR-143 expression is associated with lymph node involvement and correlates with outcome in pancreatic adenocarcinoma patients by Daniele Lavacchi, Simone Polvani, Antonio Taddei, Antonio Taddei, Federico Scolari, Luca Messerini, Enrico Caliman, Luca Moraldi, Alessia Guidolin, Gian Luca Grazi, Andrea Galli, Serena Pillozzi, Lorenzo Antonuzzo, Lorenzo Antonuzzo
Published 2023-12-01
Article -
18
Early changes in circulating tumor DNA (ctDNA) predict treatment response in metastatic KRAS-mutated colorectal cancer (mCRC) patients by Daniele Lavacchi, Stefania Gelmini, Adele Calabri, Gemma Rossi, Lisa Simi, Enrico Caliman, Irene Mancini, Francesca Salvianti, Giulia Petroni, Alessia Guidolin, Federico Scolari, Luca Messerini, Serena Pillozzi, Pamela Pinzani, Lorenzo Antonuzzo
Published 2023-11-01
Article -
19
Activity and Safety of NAB-FOLFIRI and NAB-FOLFOX as First-Line Treatment for metastatic Pancreatic Cancer (NabucCO Study) by Elisa Giommoni, Evaristo Maiello, Vanja Vaccaro, Ermanno Rondini, Caterina Vivaldi, Giampaolo Tortora, Laura Toppo, Guido Giordano, Tiziana Pia Latiano, Cinzia Lamperini, Serena Pillozzi, Luca Boni, Lorenzo Antonuzzo, Francesco Di Costanzo
Published 2021-05-01
Article -
20
Absolute eosinophil count predicts clinical outcomes and toxicity in non-small cell lung cancer patients treated with immunotherapy by Enrico Caliman, Sara Fancelli, Carlotta Ottanelli, Francesca Mazzoni, Luca Paglialunga, Daniele Lavacchi, Marta Rita Gatta Michelet, Elisa Giommoni, Brunella Napolitano, Federico Scolari, Luca Voltolini, Camilla Eva Comin, Serena Pillozzi, Lorenzo Antonuzzo
Published 2022-01-01
Article